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Recently, autoantibodies directed against a cytoplasmic antigen of human neu-
trophil granulocytes (anti-neutrophil cytoplasm antibodies [ACPA ; also known as
ANCA]) have been described to be closely associated with Wegener's granuloma-
tosis, a granulomatous disorder associated with systemic necrotizing vasculitis (1-3) .
Furthermore, ACPA serum concentration appears to be correlated with disease ac-
tivity (1, 4-7) . Together with the known involvement of granulocytes in granuloma
formation, a hallmark of Wegener's granulomatosis, this correlation supports the
hypothesis that ACPA play a pathogenetic role (8) . Therefore, identification of the
target antigen ofACPA is of crucial importance for further investigations into the
pathogenesis ofthis disease . Here we report thatACPA are directed against an elastino-
lytic neutral serine proteinase, which is most probably identical with the recently
described proteinase 3 (9-11), the third neutral serine proteinase ofhuman neutrophils .
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Materials and Methods
BriefDefinitive Report
Purification of the Target Antigen ofACPA .
￿
The target antigen ofACPA was released from
human neutrophils during degranulation induced byPMA (12) and was further purified by
affinity chromatography using a column with bound IgG from an ACPA-positive serum as
described previously (13) .
SDS-PAGE andImmunoblotting.
￿
The affinity-purified antigen was separated in 20% acryl-
amide gels under reducing or nonreducing conditions using a PhastSystem (Pharmacia/LKB
Biotechnology, Uppsala, Sweden) . After electrophoretic transfer to a polyvinylidene difluo-
ride membrane (Millipore Corp ., Bedford, MA) by semi-dry blotting (14), the membrane
was cut into strips and blocked in PBS containing2% casein (PBStcasein) . Serum pools from
ACPA-positive sera or from healthy donors (13) were added in dilutions of 1/100 in PBS/casein
and incubated for 2 h, followed by four washings with PBS containing 0.05% Tween 20
(PBSt1ween) . After incubation for 2 h with gold-linked anti-human IgG (Janssen Life Sciences
Products, Olen, Belgium) diluted 1/100 in PBS/casein, the membrane strips were washed four
times with PBS/Tween and two times with distilled water. To enhance the gold signal, a silver
enhancement mixture (Janssen Life Sciences Products) was added for 10 min, followed by
washing with distilled water and airdrying.
In some experiments human neutrophil elastase and cathepsin G (Calbiochem-Behring
Corp., San Diego, CA) were separated in parallel under nonreducing conditions . Immunodetec-
tion was done as described above with sheep anti-elastase and sheep anti-cathepsin G an-
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tisera (Serotec, Oxon, England) followed by rabbit anti-sheep IgG (Sigma Chemical Co.,
St. Louis, MO) and gold-linked goat anti-rabbit IgG (Janssen Life Sciences Products).
Silver staining of gels was done with a staining kit (Sigma Chemical Co.) according to
the manufacturer's instructions. Molecular weights were estimated by means of a low molec-
ular weight calibration kit (Pharmacia/LKB Biotechnology) separated under reducing con-
ditions.
Partial Amino Acid Sequence Analysis.
￿
To obtain sequence data the antigen preparation was
separated in SDS-PAGE under nonreducing conditions and transferred electrophoretically
to a polyvinylidene difluoride membrane as described above. The membrane was stained
with Coomassie Blue and the band containing the antigen was cut out and subjected to se-
quence analysis in a gas-phase sequencer (model 470; Applied Biosystems, Inc., Foster City,
CA) as described elsewhere (15). The MIPSX database (Martinsrieder Institut fur Proteinse-
quenzen, Martinsried, FRG), which contains all available protein and nucleic acid databases,
was used for sequence comparison.
Cleavage of Substrates.
￿
Cleavage of a-naphthyl acetate and synthetic peptides by the an-
tigen and the influence of enzyme inhibitors on esterase activity were analyzed as described
in detail elsewhere (11). Assays for cleavage of synthetic peptides included the positive con-
trols elastase, cathepsin G, and trypsin. To investigate elastinolytic activity, the antigen was
separated in SDS-PAGE under nonreducing conditions and the electrophoresis gel was layered
on top of an agarose plate containing finely pulverized (smaller than 37 Am) bovine neck
ligament elastin labeled with fluorescein (Elastin Products Company, Inc., Pacific, MO), pre-
pared according to the manufacturer's instructions. After an incubation period of 16 h at
37°C the gel was removed and the plate was photographed with indirect illumination against
a black background.
Results and Discussion
The affinity-purified antigen was applied to SDS-PAGE under reducing or non-
reducing conditions followed by immunoblotting. Under reducing conditions SDS-
PAGE revealed two main protein bands and a minor one with molecular masses
between 26 and 28 kD (Fig. 1, lanes 1 and 2). Using sera containing ACPA in immu-
noblotting, no reaction could be observed with any of the reduced proteins (Fig.
1, lane 3). Separation of the antigen under nonreducing conditions revealed a rela-
tively diffuse band in protein staining and immunoblotting (Fig. 1, lanes 4 and 5),
with the main density in the molecular weight range of 38 kD. A serum pool of 10
healthy donors showed no reaction with the antigen separated under nonreducing
conditions (Fig. 1, lane 6). The observation that the immunoreactivity of the an-
tigen was totally abolished when disulfide bonds were cleaved by reduction with 2-ME
indicates that the autoantibodies are directed against a conformational epitope of
the protein.
The amino acid sequence of the NH2 terminus of the antigen was obtained in
two independent determinations. The first sequence analysis revealed 9 NH2-ter-
minal amino acids and the second analysis with antigen prepared from different
donors extended the sequence information to the 17 NH2-terminal amino acids Ile-
Val-Gly-Gly-His-Glu-Ala-Gln-Pro-His-Ile-Arg-Pro-IleTyr-Met-Ala. This sequence
was not identical with any of the sequences listed in the January 1989 release of
the MIPSX database. However, some considerable homologies with known serine
proteinases were detected (Fig. 2), especially the highly conserved NH2-terminal
sequence Ile/Val-Ile/Val-Gly-Gly in connection with Pro in position 13 . Interest-
ingly, the two well-characterized neutral serine proteinases of human neutrophils,
elastase (16) and cathepsin G (17), and the recently described proteinase 3 (10) shareconsiderable NH2-terminal sequence homology with the antigen (Fig . 2) . Evidence
that the antigen is a serine esterase has been reported recently by Goldschmeding
et al . (18)whowere able to immunoprecipitate a29-kDprotein labeled with tritiated
diisopropyl fluorophosphate (inhibitor ofserine proteinases) usingACPA-positive sera.
These results encouraged us to investigate the enzymatic activity of the antigen .
Initially we found that the antigen is able to cleave a-naphthyl acetate, a substrate
that is hydrolyzed by many proteinases . ThepH optimum for esterase activity with
ot-naphthyl acetate was between 6.75 and 7.25, indicating that it is a neutral pro-
teinase . Assays using this substrate at pH 7.0 demonstrated that the specific activity
ofthe antigenwas -60% that ofelastase and -130% that of cathepsinG. The specific
substrates forhumanleukocyte elastase (Suc-Ala-Ala-Ala-pNA, Suc-Ala-Ala-Val-pNA,
and MeO-Suc-Ala-Ala-ProVal-pNA), forcathepsinG(Suc-Ala-Ala-Pro-Phe-pNA),
andfortrypsin (Tosyl-Arg-Methyl-ester) were not hydrolyzed by the antigen . To in-
vestigate ifthe antigen is active against elastin, it was separated in SDS-PAGE under
nonreducing conditions and theelectrophoresis gel was layered on topofan agarose
gel containing insoluble elastin particles . Under these conditions the antigen had
considerable elastinolytic activity (Fig . 3, lane 3) . The positions of elastase and
cathepsinG in the electrophoresis gel were clearly distinct from that ofthe antigen,
as demonstrated byimmunological detection oftheseenzymeswith specific antisera
(Fig. 3, lanes 4 and 5), which did not react with the antigen (not shown) . The con-
clusion drawn from the sequence data that the target antigen ofACPA is a serine
protease was further substantiated by using inhibitors with relative enzyme class
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FIGURE 1 .
￿
SDS-PAGE andimmunoblottingofthe target antigen
ofACPA. Silver-stained molecular weight markers (lane 1) and
target antigen ofACPA separatedunder reducing(lane 2) andnon-
reducing (lane 4) conditions . Immunoblot ofthe antigen separated
under reducing(lane 3) or nonreducing(lanes 5 and 6) conditions
probed with a serum pool containing ACPA (lanes 3 and 5) or
a serum pool from healthy donors (lane 6). Relative molecular
masses ofthe marker proteins areshown on the left in kilodaltons .
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FIGURE 2 .
￿
NH2-terminal sequence of the
target antigen ofACPA compared with the
humanlymphocyte protease granzyme2 (22),
mousemucosal mast cell protease (23), human
neutrophil cathepsin G (17), human neutro-
phil elastase(16), andhuman neutrophil pro-
teinase 3 (10). Ofproteinase 3 only 14 NH2-
terminal amino acids have been published in
aPh.D Thesis (10) . Theone letter amino acid
code is used (X = not identified) . The gap
(-) in position 14 is introduced to optimize
identity.360
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FIGURE 3 .
￿
Degradation ofelastin by the target antigen ofACPA (lane
3) andimmunoblot ofthe antigen (lane 2),human neutrophil elastase
(lane 4), and human neutrophil cathepsin G (lane 5), all separated
in SDS-PAGE undernonreducing conditions . Thedark band in lane
3 shows loss oflight scattering under indirect illumination due to degra-
dation ofthe elastin particles . Relative molecular masses ofthe marker
proteins separated under reducing conditions (lane 1) are shown on
the left in kilodaltons .
specificity. Thea-naphthyl acetate esterase activity wasnot inhibited by 10p.M pep-
statin (inhibitor ofcarbonyl proteinases), 1mM N-ethylmaleimide (inhibitor ofthiol
proteinases), or 5mM EDTA (inhibitor of metalloproteinases) butby 1 mM PMSF
(inhibitor ofserine proteinases) . In addition we were able to inhibit esterase activity
ofthe antigen with 514M soybean trypsin inhibitor, another inhibitor of serine pro-
teinases .
Since the molecular weight of the three isoforms of the antigen, its substrate
specificity, and its inhibitor profile reported in this study are identical with those
reported recently for proteinase 3 (10, 11), we conclude that ACPA are most prob-
ably directed against proteinase 3. This was further substantiated by purifyingthe
antigen with the same chromatographic techniques described by Kao et al . (11) for
isolation of proteinase 3 . The differences in the NH2-terminal amino acid sequence
(Fig . 2) could be due either to microheterogeneity or inaccuracies in one of the se-
quence analyses . Very recently the NH2-terminal amino acid sequence ofa 29-kD
antimicrobial protein from human neutrophils, which is almost identical to that of
the antigen, has been reported (19) . It is very likely that this protein is also identical
with proteinase 3, but that must be proven by functional studies .
Proteinase 3 possesses elastinolytic activity and therefore may play a role in the
destruction of tissue . It has been shown that proteinase 3 is, along with elastase,
only the second enzyme purified from human phagocytes that causes experimental
emphysema (10, 11) . Elastase has been reported to be partially responsible fortissue
injury in vasculitis (20) and to function as a major proteinase in granulomatous
tissue remodeling (21) . Proteinase 3 also digests elastin and may therefore induce
pathological alterations similar to those induced by elastase . In preliminary experi-
ments we found that binding of ACPA to the antigen did not inhibit its enzyme
activity, but possibly the autoantibodies prevent the enzyme from being inactivated
by its natural inhibitors . A thus uninhibited proteinase digesting elastic fibers in
vessel walls could cause a necrotizing vasculitis and may also be involved in granu-
loma formation, which are the two major histopathological findings in Wegener's
granulomatosis . Further investigations into the biological functions of proteinase
3 and its physiological inhibitors might give more insight into the pathomechanisms
not only of vasculitis and pulmonary emphysema but also of other inflammatory
disorders .LODEMANN ET AL.
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Summary
The target antigen of anti-neutrophil cytoplasm antibodies (ACPA; also known
as ANCA) was isolated by affinity chromatography from supernatants of human
neutrophils, stimulated with phorbol ester to induce degranulation. Sequence anal-
ysis of the antigen revealed 17 NH2-terminal amino acids (IVGGHEAQPHIR-
PIYMA), which have considerable sequence homology with known serine proteinases.
Investigation of the enzymatic activity showed that the antigen is a neutral serine
proteinase that is able to cleave elastin. Since the molecular weight of the antigen,
its substrate specificity, and its inhibitor profile reported in this study are identical
with those reported recently for proteinase 3, we conclude that ACPA are most probably
directed against proteinase 3 .
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